ASX:EMV

EMvision Medical Devices Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume192,157 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive EMV News and Ratings via Email

Sign-up to receive the latest news and ratings for EMvision Medical Devices and its competitors with MarketBeat's FREE daily newsletter.


About EMvision Medical Devices

EMvision Medical Devices Limited engages in the research, development, and commercialization of imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, and other medical imaging needs. The company has a strategic collaboration with Keysight Technologies Malaysia Sdn Bhd to develop a personalized vector network analysis solution for medical imaging in the healthcare sector. EMvision Medical Devices Limited was founded in 2017 and is based in Macquarie Park, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.86 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











EMvision Medical Devices (ASX:EMV) Frequently Asked Questions

What stocks does MarketBeat like better than EMvision Medical Devices?

Wall Street analysts have given EMvision Medical Devices a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but EMvision Medical Devices wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were EMvision Medical Devices' earnings last quarter?

EMvision Medical Devices Limited (ASX:EMV) posted its quarterly earnings results on Tuesday, February, 26th. The company reported ($4.47) EPS for the quarter.
View EMvision Medical Devices' earnings history
.

Who are EMvision Medical Devices' key executives?

EMvision Medical Devices' management team includes the following people:
  • Dr. Ronald Peter Weinberger, CEO, MD & Director
  • Mr. Scott Kirkland, Exec. Director
  • Ms. Emma Waldon, CFO & Company Sec. (Age 45)
  • Dr. Konstanty Bialkowski, Head of Technology Devel.
  • Prof. Stuart Crozier B.E., M.Sc., Ph.D., Chairman of Clinical Advisory Board & Chief Scientific Officer
  • Mr. Robert Tiller, Head of Design
  • Ms. Ruth Cremin, Head of Quality & Regulatory Affairs
  • Ms. Forough Khandan, Head of Program Management

Who are some of EMvision Medical Devices' key competitors?

What is EMvision Medical Devices' stock symbol?

EMvision Medical Devices trades on the ASX under the ticker symbol "EMV."

How much money does EMvision Medical Devices make?

EMvision Medical Devices has a market capitalization of $0.00 and generates $2.07 million in revenue each year.

What is EMvision Medical Devices' official website?

The official website for EMvision Medical Devices is www.emvision.com.au.

How can I contact EMvision Medical Devices?

The company can be reached via phone at 61 2 8667 5337.


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.